Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare
Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcareSanofi and CD&R enter exclusive negotiations to transfer a 50% ...
BioSpace4d
As Sanofi Preps Consumer Healthcare Sale, Here’s a Look Back at Similar High-Profile Deals
When Sanofi announced last week that it plans to sell a 50% controlling stake of Opella, its consumer helath business, the ...
FiercePharma9d
Sanofi enters talks with private equity firm to sell controlling stake in consumer health unit Opella
With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a ...
CD&R Plans Measures to Ease French Worries on Sanofi Deal
Clayton Dubilier & Rice is working on a package of commitments amid political concerns that its purchase of a controlling ...
France's PAI Partners Ups Bid for Sanofi's Consumer Health Division As French Government Hints Possible Regulatory Block
Sanofi is in talks with CD&R to sell a 50% stake in its consumer healthcare unit, Opella. PAI Partners raised its bid by 200 ...
PAI Partners raises offer for Sanofi's consumer unit - reports
PAI Partners raises offer for Sanofi's consumer health unit, Opella, by €200 million and aims to keep key operations in ...
PAI Partners Submits Improved Bid on Sanofi's Consumer Unit
PAI partners submitted an improved bid for Sanofi's consumer health business, in an attempt to reenter the race for what could be one of the pharma industry's biggest deals this year.
Sanofi enters exclusive talks with CD&R for Opella sale
Sanofi said on Monday it had entered exclusive talks for the sale of a 50% controlling stake in its consumer health business ...
France says it has received assurances over sale of painkiller maker to US investment fund CD&R
The proposed sale turned into a real political issue because Opella's products include Doliprane, the best-selling medicine ...